The Investigation of Acute Effects of Action Observation Training on Upper Extremity Functionality, Reaction Time and Cognitive Functions in Right-handed Healthy Subjects

• Sponsor: Dokuz Eylul University (Other)
• Overall Status: Completed
• CT.gov ID: NCT04932057
• Collaborator: Izmir Katip Celebi University (Other)
• Enrollment: 60
• Location: 1
• Arms: 5
• Actual Duration (Months): 2
• Patients Per Site Per Month: 29.5

Study Details

Study Description

Brief Summary

The aim of the study is to investigate the acute effects of action observation training on upper extremity functionality, reaction times, and cognitive functions in right-handed healthy subjects.

Condition or Disease	Intervention/Treatment	Phase
Right-handed Healthy Adults	Other: Action observation Training; Other: Action Practice; Other: Observation	N/A

Study Design

• Study Type: Interventional
• Actual Enrollment: 60 participants
• Allocation: Randomized
• Intervention Model: Sequential Assignment
• Masking: Double (Participant, Outcomes Assessor)
• Primary Purpose: Treatment
• Official Title: The Investigation of Acute Effects of Action Observation Training on Upper Extremity Functionality, Reaction Time and Cognitive Functions in Right-handed Healthy Subjects
• Actual Study Start Date: Jul 1, 2021
• Actual Primary Completion Date: Aug 16, 2021
• Actual Study Completion Date: Sep 1, 2021

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Self-Action Observation (s-AO Group) Participants will watch their own actions during an upper extremity functionality test.	Other: Action observation Training; Action observation training is a relatively new rehabilitation approach in which the subject is asked to carefully observe the actions presented through a video clip or performed by an operator.
Experimental: Action Observation (AO Group) Participants will watch a person while performing an upper extremity functionality test.	Other: Action observation Training; Action observation training is a relatively new rehabilitation approach in which the subject is asked to carefully observe the actions presented through a video clip or performed by an operator.
Active Comparator: Action Practice Participants will perform an upper extremity task 4 more times.	Other: Action Practice; Participants perform an upper extremity functionality test a couple of times.
Placebo Comparator: Observation Participants will watch a slide show which will only contain landscapes.	Other: Observation; Participants will watch a slide show of landscape
No Intervention: Control Participants will wait without any performance till the second assesment.

Outcome Measures

Primary Outcome Measures

1. Change in upper extremity functionality [The outcome will be assessed at baseline and immediately after the intervention.]

   Jebsen-Taylor Hand Function Test will be used

2. Change in upper extremity dexterity [The outcome will be assessed at baseline and immediately after the intervention.]

   Nine-Hole Peg Test will be used.

3. Change in cognitive functions [The outcome will be assessed at baseline and immediately after the intervention.]

   Serial Reaction Time Task will be used.

4. Change in cognitive functions [The outcome will be assessed at baseline and immediately after the intervention.]

   d2 Test of Attention will be used.

5. Change in reaction time [The outcome will be assessed at baseline and immediately after the intervention.]

   Ruler drop test will be used.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 30 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• 18 years old

• willingness

Exclusion Criteria:

• any kind of neurological or musculoskeletal problems

• sight problems

• pain in the upper limb

• left handedness

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Izmir Katip Celebi University	Izmir		Turkey	35620

Sponsors and Collaborators

• Dokuz Eylul University
• Izmir Katip Celebi University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Yusuf EMUK, Principal Investigator, Dokuz Eylul University
• ClinicalTrials.gov Identifier: NCT04932057
• Other Study ID Numbers: Izmir Katip Celebi University
• First Posted: Jun 18, 2021
• Last Update Posted: Oct 27, 2021
• Last Verified: Oct 1, 2021

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Study Results

No Results Posted as of Oct 27, 2021